Taro Pharmaceutical Industries Ltd.

TARO

Statistics

$105.07Share Price
$4.2 BMarket Cap
14.7%EBIT / EV
13.7%FCF / EV
59.7%ROIC
55.4%Cash ROIC
5.4%3yr Avg Revenue Growth
9.56Current Ratio
star logo

Business Model Diligence

We do not yet have Business Model Diligence for this stock.

Statistical Diligence

gray wandCurrent member of one or more spells! Log in to see which ones.
check mark The EBIT / Enterprise Value of 14.7% ranks as Very High.
check mark The Free Cash Flow / Enterprise Value of 13.7% ranks as Very High.
check mark The Return on Invested Capital Value of 59.7% ranks as Very High.
check mark The Cash Return on Capital Value of 55.4% ranks as Very High.
check mark The 3 Year Average Revenue Growth Value of 5.4% ranks as Average.
check mark Near-term Financial Health appears to be Very Good. The Current Ratio is 9.56.

Company Description

Taro Pharmaceutical Industries Ltd. engages in the development, manufacturing, and marketing of prescription and over-the-counter pharmaceutical products in the U.S., Canada, and Israel. Its products are used for dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories. It offers semi-solids formulations such as creams and ointments; and other dosage forms including liquids, capsules, and tablets. The company was founded in 1950 and is headquartered in Haifa Bay, Israel.

Calculations

You must have a MagicDiligence Membership to view the Calculations for this stock. If you are already a member, you need to log in first.
Tracking Portfolios
blue wand Magic Recipe 29.36%
purple wand Deep Value 24.71%
orange wand Quality Growth 44.22%
green wand Green Team 6.14%
red dot Red Rating 5.76%
yellow dot Yellow Rating 14.17%
green dot Green Rating 14.95%
New Spell Stocks
purple wand New Stocks Added!
orange wand New Stocks Added!